| A guide to ComBat harmonization of imaging biomarkers in multicenter studies F Orlhac, JJ Eertink, AS Cottereau, JM Zijlstra, C Thieblemont, M Meignan, ... Journal of Nuclear Medicine 63 (2), 172-179, 2022 | 204 | 2022 |
| 18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma JJ Eertink, T van de Brug, SE Wiegers, GJC Zwezerijnen, EAG Pfaehler, ... European journal of nuclear medicine and molecular imaging, 1-11, 2022 | 99 | 2022 |
| Proposed new dynamic prognostic index for diffuse large B-cell lymphoma: international metabolic prognostic index NG Mikhaeel, MW Heymans, JJ Eertink, HCW De Vet, R Boellaard, ... Journal of Clinical Oncology 40 (21), 2352-2360, 2022 | 93 | 2022 |
| Automated segmentation of baseline metabolic total tumor burden in diffuse large B-cell lymphoma: which method is most successful? A study on behalf of the PETRA consortium SF Barrington, BGJC Zwezerijnen, HCW de Vet, MW Heymans, ... Journal of Nuclear Medicine 62 (3), 332-337, 2021 | 83 | 2021 |
| Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients JJ Eertink, CN Burggraaff, MW Heymans, U Dührsen, A Hüttmann, ... Blood advances 5 (9), 2375-2384, 2021 | 55 | 2021 |
| External validation: A simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data … JJ Eertink, MW Heymans, GJC Zwezerijnen, JM Zijlstra, HCW de Vet, ... EJNMMI research 12 (1), 58, 2022 | 45 | 2022 |
| The impact of semiautomatic segmentation methods on metabolic tumor volume, intensity, and dissemination radiomics in 18F-FDG PET scans of patients with classical Hodgkin lymphoma J Driessen, GJC Zwezerijnen, H Schöder, EEE Drees, MJ Kersten, ... Journal of Nuclear Medicine 63 (9), 1424-1430, 2022 | 42 | 2022 |
| Quantitative radiomics features in diffuse large B-cell lymphoma: does segmentation method matter? JJ Eertink, EAG Pfaehler, SE Wiegers, PJ Lugtenburg, OS Hoekstra, ... Journal of Nuclear Medicine 63 (3), 389-395, 2022 | 34 | 2022 |
| Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma JJ Eertink, GJC Zwezerijnen, MW Heymans, S Pieplenbosch, SE Wiegers, ... Blood, The Journal of the American Society of Hematology 141 (25), 3055-3064, 2023 | 33 | 2023 |
| Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features JJ Eertink, GJC Zwezerijnen, MCF Cysouw, SE Wiegers, EAG Pfaehler, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (13), 4642-4651, 2022 | 33 | 2022 |
| Reproducibility of [18F] FDG PET/CT liver SUV as reference or normalisation factor GJC Zwezerijnen, JJ Eertink, MC Ferrández, SE Wiegers, CN Burggraaff, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (2), 486-493, 2023 | 23 | 2023 |
| An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients MC Ferrández, SSV Golla, JJ Eertink, BM de Vries, PJ Lugtenburg, ... Scientific Reports 13 (1), 13111, 2023 | 15 | 2023 |
| Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods MC Ferrández, JJ Eertink, SSV Golla, SE Wiegers, GJC Zwezerijnen, ... EJNMMI research 12 (1), 44, 2022 | 15 | 2022 |
| 18F-FDG PET improves baseline clinical predictors of response in diffuse large B-cell lymphoma: the HOVON-84 study CN Burggraaff, JJ Eertink, PJ Lugtenburg, OS Hoekstra, AIJ Arens, ... Journal of Nuclear Medicine 63 (7), 1001-1007, 2022 | 15 | 2022 |
| Interobserver agreement on automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F-FDG PET in diffuse large B-cell lymphoma GJC Zwezerijnen, JJ Eertink, CN Burggraaff, SE Wiegers, EAIN Shaban, ... Journal of Nuclear Medicine 62 (11), 1531-1536, 2021 | 13 | 2021 |
| Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma JJ Eertink, GJC Zwezerijnen, SE Wiegers, S Pieplenbosch, ... Blood Advances 7 (2), 214-223, 2023 | 10 | 2023 |
| The optimal timing of interim 18F-FDG PET in diffuse large B-cell lymphoma: An individual patient data meta-analysis by the Petra consortium JJ Eertink, CN Burggraaff, MW Heymans, SF Barrington, G Mikhaeel, ... Blood 134, 487, 2019 | 10 | 2019 |
| Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma EEE Drees, J Driessen, GJC Zwezerijnen, SAWM Verkuijlen, JJ Eertink, ... EJHaem 3 (3), 908-912, 2022 | 9 | 2022 |
| Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma J Driessen, GJC Zwezerijnen, H Schöder, MJ Kersten, AJ Moskowitz, ... Blood advances 7 (21), 6732-6743, 2023 | 8 | 2023 |
| Profound regional spectral, connectivity, and network changes reflect visual deficits in posterior cortical atrophy: an EEG study CT Briels, JJ Eertink, CJ Stam, WM van der Flier, P Scheltens, AA Gouw Neurobiology of aging 96, 1-11, 2020 | 7 | 2020 |